Skip to content

GILD

Gilead Sciences, Inc.

EBITDA, 2025
$12.8B
YoY, 2025
+188.6%
5-year CAGR
+18.2%
10-year CAGR
−5.8%

EBITDA

EBITDA by fiscal year

PeriodEBITDAYoY
2025$12.8B+188.6%
2024$4.4B−57.0%
2023$10.3B+9.2%
2022$9.4B−21.2%
2021$12.0B+115.6%
2020$5.6B−2.5%
2019$5.7B−40.9%
2018$9.6B−37.5%
2017$15.4B−18.0%
2016$18.8B−19.3%
2015$23.3B+42.8%
2014$16.3B+235.1%
2013$4.9B+13.5%
2012$4.3B+4.8%
2011$4.1B−3.2%
2010$4.2B+13.0%
2009$3.7B+32.0%
2008$2.8B+25.1%
2007$2.3B—